Mechanisms affecting the implementation of a national antimicrobial stewardship programme; multi-professional perspectives explained using normalisation process theory.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
02 07 2020
Historique:
received: 24 01 2020
accepted: 23 06 2020
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 13 7 2021
Statut: epublish

Résumé

Antimicrobial stewardship (AMS) describes activities concerned with safe-guarding antibiotics for the future, reducing drivers for the major global public health threat of antimicrobial resistance (AMR), whereby antibiotics are less effective in preventing and treating infections. Appropriate antibiotic prescribing is central to AMS. Whilst previous studies have explored the effectiveness of specific AMS interventions, largely from uni-professional perspectives, our literature search could not find any existing evidence evaluating the processes of implementing an integrated national AMS programme from multi-professional perspectives. This study sought to explain mechanisms affecting the implementation of a national antimicrobial stewardship programme, from multi-professional perspectives. Data collection involved in-depth qualitative telephone interviews with 27 implementation lead clinicians from 14/15 Scottish Health Boards and 15 focus groups with doctors, nurses and clinical pharmacists (n = 72) from five Health Boards, purposively selected for reported prescribing variation. Data was first thematically analysed, barriers and enablers were then categorised, and Normalisation Process Theory (NPT) was used as an interpretive lens to explain mechanisms affecting the implementation process. Analysis addressed the NPT questions 'which group of actors have which problems, in which domains, and what sort of problems impact on the normalisation of AMS into everyday hospital practice'. Results indicated that major barriers relate to organisational context and resource availability. AMS had coherence for implementation leads and prescribing doctors; less so for consultants and nurses who may not access training. Conflicting priorities made obtaining buy-in from some consultants difficult; limited role perceptions meant few nurses or clinical pharmacists engaged with AMS. Collective individual and team action to implement AMS could be constrained by lack of medical continuity and hierarchical relationships. Reflexive monitoring based on audit results was limited by the capacity of AMS Leads to provide direct feedback to practitioners. This study provides original evidence of barriers and enablers to the implementation of a national AMS programme, from multi-professional, multi-organisational perspectives. The use of a robust theoretical framework (NPT) added methodological rigour to the findings. Our results are of international significance to healthcare policy makers and practitioners seeking to strengthen the sustainable implementation of hospital AMS programmes in comparable contexts.

Sections du résumé

BACKGROUND
Antimicrobial stewardship (AMS) describes activities concerned with safe-guarding antibiotics for the future, reducing drivers for the major global public health threat of antimicrobial resistance (AMR), whereby antibiotics are less effective in preventing and treating infections. Appropriate antibiotic prescribing is central to AMS. Whilst previous studies have explored the effectiveness of specific AMS interventions, largely from uni-professional perspectives, our literature search could not find any existing evidence evaluating the processes of implementing an integrated national AMS programme from multi-professional perspectives.
METHODS
This study sought to explain mechanisms affecting the implementation of a national antimicrobial stewardship programme, from multi-professional perspectives. Data collection involved in-depth qualitative telephone interviews with 27 implementation lead clinicians from 14/15 Scottish Health Boards and 15 focus groups with doctors, nurses and clinical pharmacists (n = 72) from five Health Boards, purposively selected for reported prescribing variation. Data was first thematically analysed, barriers and enablers were then categorised, and Normalisation Process Theory (NPT) was used as an interpretive lens to explain mechanisms affecting the implementation process. Analysis addressed the NPT questions 'which group of actors have which problems, in which domains, and what sort of problems impact on the normalisation of AMS into everyday hospital practice'.
RESULTS
Results indicated that major barriers relate to organisational context and resource availability. AMS had coherence for implementation leads and prescribing doctors; less so for consultants and nurses who may not access training. Conflicting priorities made obtaining buy-in from some consultants difficult; limited role perceptions meant few nurses or clinical pharmacists engaged with AMS. Collective individual and team action to implement AMS could be constrained by lack of medical continuity and hierarchical relationships. Reflexive monitoring based on audit results was limited by the capacity of AMS Leads to provide direct feedback to practitioners.
CONCLUSIONS
This study provides original evidence of barriers and enablers to the implementation of a national AMS programme, from multi-professional, multi-organisational perspectives. The use of a robust theoretical framework (NPT) added methodological rigour to the findings. Our results are of international significance to healthcare policy makers and practitioners seeking to strengthen the sustainable implementation of hospital AMS programmes in comparable contexts.

Identifiants

pubmed: 32616015
doi: 10.1186/s13756-020-00767-w
pii: 10.1186/s13756-020-00767-w
pmc: PMC7330968
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

99

Références

J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
J Hosp Infect. 2018 Nov;100(3):245-256
pubmed: 29966757
J Antimicrob Chemother. 2018 Mar 1;73(3):804-813
pubmed: 29237051
Am J Infect Control. 2018 May;46(5):492-497
pubmed: 29395509
Clin Microbiol Infect. 2014 Oct;20(10):954-62
pubmed: 25294340
Int J Antimicrob Agents. 2013 Mar;41(3):203-12
pubmed: 23127482
Expert Rev Anti Infect Ther. 2015 May;13(5):665-80
pubmed: 25813839
Implement Sci. 2016 Oct 19;11(1):141
pubmed: 27756414
Lancet Infect Dis. 2017 Sep;17(9):990-1001
pubmed: 28629876
Implement Sci. 2009 May 21;4:29
pubmed: 19460163
Antimicrob Resist Infect Control. 2017 Aug 15;6:81
pubmed: 28824799
Int J Nurs Stud. 2017 Jun;71:A1-A3
pubmed: 28318533
BMC Fam Pract. 2007 Jul 24;8:42
pubmed: 17650326
Am J Infect Control. 2018 Dec;46(12):1365-1369
pubmed: 30077436
Infect Dis Health. 2017 Sep;22(3):97-104
pubmed: 31862093
Clin Infect Dis. 2013 Jul;57(2):188-96
pubmed: 23572483
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Clin Microbiol Infect. 2017 Nov;23(11):793-798
pubmed: 28882725
Hosp Pharm. 2019 Aug;54(4):250-258
pubmed: 31320775
Clin Microbiol Infect. 2015 Feb;21(2):180.e1-7
pubmed: 25658564
BMC Med Inform Decis Mak. 2014 Jun 05;14:45
pubmed: 24898694
Clin Infect Dis. 2016 Jan 1;62(1):84-9
pubmed: 26265496
Implement Sci. 2018 Jun 7;13(1):80
pubmed: 29879986
Am J Infect Control. 2018 Jul;46(7):737-742
pubmed: 29729830
Int J Nurs Stud. 2014 Feb;51(2):289-99
pubmed: 23910398
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Infect Control Hosp Epidemiol. 2014 Oct;35(10):1209-28
pubmed: 25203174
J Antimicrob Chemother. 2015 Sep;70(9):2665-70
pubmed: 26080364

Auteurs

Kay Currie (K)

Glasgow Caledonian University, Glasgow, UK. k.currie@gcu.ac.uk.

Rebecca Laidlaw (R)

Glasgow Caledonian University, Glasgow, UK.

Valerie Ness (V)

Glasgow Caledonian University, Glasgow, UK.

Lucyna Gozdzielewska (L)

Glasgow Caledonian University, Glasgow, UK.

William Malcom (W)

Health Protection Scotland, Glasgow, UK.

Jacqueline Sneddon (J)

Healthcare Improvement Scotland, Glasgow, UK.

Ronald Andrew Seaton (RA)

Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK.

Paul Flowers (P)

Glasgow Caledonian University, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH